COMMUNIQUÉS West-GlobeNewswire

A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies' access efforts are

10/09/2024 - 14:00

AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue of how some of the largest pharmaceutical companies are reaching [...]

Un nouveau rapport de l’Access to Medicine Foundation révèle à quel point les efforts des entreprises pharmaceutiques en matière d’accès aux médicaments sont axés sur les patients

10/09/2024 - 14:00

AMSTERDAM, 10 sept. 2024 (GLOBE NEWSWIRE) -- Le dernier rapport de l’Access to Medicine Foundation se penche pour la première fois sur la question cruciale de l’approche de certaines des plus grandes entreprises [...]

Vaping Expected to Increase COPD Health and Economic Burden by 2050

10/09/2024 - 14:00

New ResMed-supported research presented at ERS 2024 projects future Chronic Obstructive Pulmonary Disease (COPD) burden in Western Europe, accounting for increased air pollution, tobacco smoking, and vaping, with Non- [...]

Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024

10/09/2024 - 14:00

SAN DIEGO, CA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma,” “Connect” or the “Company”), a U.S.-headquartered global clinical-stage biopharmaceutical company [...]

Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference

10/09/2024 - 14:00

CARLSBAD, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management [...]

Korro to Participate in Upcoming Investor Conferences

10/09/2024 - 14:00

CAMBRIDGE, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and [...]

Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory Society International Congress 2024

10/09/2024 - 14:00

SOUTH SAN FRANCISCO, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the [...]

Passage Bio Welcomes Tom Kassberg to Board of Directors

10/09/2024 - 13:52

PHILADELPHIA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced [...]

BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+™ for Prostate Cancer

10/09/2024 - 13:50

BriaCell has received positive feedback from its Pre-Investigational New Drug Application (Pre-IND) meeting with FDA for Bria-PROS+™ in prostate cancer The meeting provides a clear path towards filing an IND and [...]

Altimmune Presents Results of a Phase 2 MRI-Based Body Composition Sub-Study at 60th Annual Meeting of the European Association for the Study of Diabetes

10/09/2024 - 13:45

Lean Loss Ratio of only 21.9%, representing class-leading preservation of lean mass Maintenance of lean mass preservation in individuals over the age of 60, a population at risk for frailty-related falls and fractures [...]

Jasper Therapeutics Announces Health Canada Clearance of Clinical Trial Application for Phase 1b/2a Study of Briquilimab in Asthma

10/09/2024 - 13:30

REDWOOD CITY, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy [...]

Nanox to Participate in Upcoming Investor Conference in September 2024

10/09/2024 - 13:30

PETACH TIKVA, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that Company management will [...]

Reunion Neuroscience Appoints Mark Pollack, M.D., as Chief Medical Officer

10/09/2024 - 13:30

MORRISTOWN, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserved mental health disorders through the [...]

Opthea to Have Significant Presence at the 24ᵗʰ EURETINA Congress and EURETINA Innovation Spotlight

10/09/2024 - 13:30

MELBOURNE, Australia and PRINCETON, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat [...]

Kura Oncology to Participate in Cantor Global Healthcare Conference

10/09/2024 - 13:30

SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today [...]

Business Insurance Honors CorVel with Two Awards in 2024

10/09/2024 - 13:15

FORT WORTH, Texas, Sept. 10, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a national provider of risk management solutions, today announced that it has received two awards from Business Insurance in 2024 [...]

Aveanna to Participate at the Deutsche Bank Annual Leveraged Finance Conference

10/09/2024 - 13:00

ATLANTA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Deutsche Bank Annual Leveraged Finance Conference in [...]

Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources

10/09/2024 - 13:00

Ms. Thompson Brings Nearly 25 Years of HR Leadership Driving Top Performing Cultures and Building Exceptional Teams CHASKA, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore [...]

ONL Therapeutics to Present at the 57th Annual Scientific Meeting of The Retina Society and EURETINA Innovation Spotlight

10/09/2024 - 13:00

ANN ARBOR, Mich., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today [...]